Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
104714-1 Hepatitis C virus RNA LaCnc Ser/Plas Pt Qn Molgen   ACTIVE Hepatitis C virus RNA [log units/volume] in Serum or Plasma by Molecular genetics method   ADD DefinitionDescription     log IU/mL             MICRO   104714-1   Molgen     Observation       0 HCV RNA SerPl-Log IU       N   HCV; Hep; Hep C; Hepatis; Hepatit; Log ACNC; Log IU; Microbiology; Molecular genetics; PCR; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.78 2.78               {Log_IU}/mL       0
104715-8 Hepatitis C virus RNA PrThr Ser/Plas Pt Ord Molgen   ACTIVE Hepatitis C virus RNA [Presence] in Serum or Plasma by Molecular genetics method   ADD DefinitionDescription                   MICRO   104715-8   Molgen     Observation       0 HCV RNA SerPl Ql       N   HCV; Hep; Hep C; Hepatis; Hepatit; Microbiology; Molecular genetics; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.78 2.78                       0
104716-6 Parainfluenza virus 4 RNA PrThr XXX Pt Ord Molgen   ACTIVE Parainfluenza virus 4 RNA [Presence] in Specimen by Molecular genetics method   ADD DefinitionDescription                   MICRO   104716-6   Molgen     Observation       0 HPIV4 RNA Spec Ql       N   HPIV; HPIV4; Human rubulavirus 4; Microbiology; Misc; Miscellaneous; Molecular genetics; Ordinal; Other; Para; Parainflu; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; Spec; To be specified in another part of the message; Unspecified 2.78 2.78                       0
104717-4 Medication name ID Medication Pt Nom     ACTIVE Medication name [Identifier] Medication   ADD DefinitionDescription                   MEDS   104717-4         Observation       0 Medication name Medication       N   Ident; Identifier; Med; MEDS; Nominal; Point in time; Random 2.78 2.78                       0
104718-2 Elliptocytes PrThr Bld Pt Ord     ACTIVE Elliptocytes [Presence] in Blood   ADD DefinitionDescription                   HEM/BC   104718-2         Observation       0 Elliptocytes Bld Ql       N   Blood; Elliptocyte; HEMATOLOGY/CELL COUNTS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood 2.78 2.78                       0
104719-0 Direction repetition timing Time ^Patient Pt Qn     ACTIVE Direction repetition timing [Time]   MIN DefinitionDescription     wk;d             CLIN   104719-0         Observation       0 Direction repetition timing Time       N   CLIN; Point in time; QNT; Quan; Quant; Quantitative; Random 2.79 2.78               wk;d     Release 2.79: EXAMPLE_UCUM_UNITS: Corrected example units; 0
10472-9 Chromogranin Ag PrThr Tiss Pt Ord Immune stain   ACTIVE Chromogranin Ag [Presence] in Tissue by Immune stain   MIN DefinitionDescription                   PATH   10472-9   Immune stain     Both       0 Cg Ag Tiss Ql ImStn           Antigen; Antigens; Cg; CGA; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified 2.73 1.0i                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
104720-8 Clinical indication Find ^Patient Pt Nar     ACTIVE Clinical indication Narrative   ADD DefinitionDescription                   CLIN   104720-8         Observation       0 Clinical indication       N   Finding; Findings; Narrative; Point in time; Random; Report 2.78 2.78                       0
104721-6 Hepatitis C virus RNA ACnc Ser/Plas Pt Qn Molgen   ACTIVE Hepatitis C virus RNA [Units/volume] in Serum or Plasma by Molecular genetics method   ADD DefinitionDescription     IU/mL             MICRO   104721-6   Molgen     Observation       0 HCV RNA SerPl-aCnc       N   Arbitrary concentration; HCV; Hep; Hep C; Hepatis; Hepatit; Microbiology; Molecular genetics; PCR; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.78 2.78               [IU]/mL       0
104722-4 Chlamydia trachomatis rRNA PrThr XXX Pt Ord Molgen   ACTIVE Chlamydia trachomatis rRNA [Presence] in Specimen by Molecular genetics method   ADD DefinitionDescription                   MICRO   104722-4   Molgen     Observation       0 C trach rRNA Spec Ql       N   C trac; C trach; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; LGV; Lymphogranuloma venereum; Microbiology; Misc; Miscellaneous; Molecular genetics; Ordinal; Other; PCR; Point in time; PR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; Spec; To be specified in another part of the message; Trachoma; Unspecified 2.78 2.78                       0
104723-2 Medication role Type ^Patient Pt Nom     ACTIVE Medication role   ADD DefinitionDescription                   MEDS   104723-2         Observation       0 Medication role       N   MEDS; Nominal; Point in time; Random; Typ 2.78 2.78                       0
104724-0 Streptococcus agalactiae DNA PrThr XXX Pt Ord Molgen   ACTIVE Streptococcus agalactiae DNA [Presence] in Specimen by Molecular genetics method   ADD DefinitionDescription                   MICRO   104724-0   Molgen     Observation       0 Gp B Strep DNA Spec Ql       N   Deoxyribonucleic acid; GBS; Gp B Strep; Group B; Group B Strep; Microbiology; Misc; Miscellaneous; Molecular genetics; Ordinal; Other; PCR; Point in time; PR; QL; Qual; Qualitative; Random; S agalactiae; Screen; Spec; Steptococcus Group B; Strep; Strep B; Strep group B; Strept; Streptococci group B; To be specified in another part of the message; Unspecified 2.78 2.78                       0
104725-7 Medication overridden safety advice Find Medication Pt Nar     ACTIVE Medication overridden safety advice Medication Narrative   ADD DefinitionDescription                   MEDS   104725-7         Observation       0 Meds overridden safety advice Medication       N   Finding; Findings; Med; MEDS; Meds overridden safety advice; Narrative; Point in time; Random; Report 2.78 2.78                       0
104726-5 Dacryocytes PrThr Bld Pt Ord     ACTIVE Dacrocytes [Presence] in Blood   ADD DefinitionDescription                   HEM/BC   104726-5         Observation       0 Dacryocytes Bld Ql       N   Blood; Dacrocyte; Dacrocytes; Dacryocyte; HEMATOLOGY/CELL COUNTS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tear drops; Teardrop cells; Teardrops; WB; Whole blood 2.78 2.78                       0
104727-3 Influenza virus A H1 2009 pandemic RNA PrThr XXX Pt Ord Molgen   ACTIVE Influenza virus A H1 2009 pandemic RNA [Presence] in Specimen by Molecular genetics method   ADD DefinitionDescription                   MICRO   104727-3   Molgen     Observation       0 FLUAV H1 2009 pand RNA Spec Ql       N   Avian influenza; Bird flu; FLUA; FLUAV; FLUAV H1; FLUAV H1 2009 pand; FLUV; Fowl plague; H1N1; H1N1v; Influ; Influenza A; Influenza A virus; Influenza virus A hemagglutinin H1 swine origin; Microbiology; Misc; Miscellaneous; Molecular genetics; Ordinal; Other; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; S-OIV; Spec; To be specified in another part of the message; Unspecified 2.78 2.78                       0
104728-1 Base excess^^standard SCnc BldV Pt Qn     DEPRECATED Deprecated Base excess standard in Venous blood   DEL DefinitionDescription     mmol/L             CHEM   104728-1         Observation       0 Deprecated Base excess std BldV-sCnc       N   Base ex; BE; Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; BSE; Chemistry; EXS; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; SBE; std; Substance Concentration; Venous 2.79 2.78       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
104729-9 Medication exceptional safety override Find ^Patient Pt Nar     ACTIVE Medication exceptional safety override Narrative   ADD DefinitionDescription                   MEDS   104729-9         Observation       0 Meds exceptional safety override       N   Finding; Findings; MEDS; Meds exceptional safety override; Narrative; Point in time; Random; Report 2.78 2.78                       0
10473-7 Chymotrypsin Ag PrThr Tiss Pt Ord Immune stain   ACTIVE Chymotrypsin Ag [Presence] in Tissue by Immune stain   MIN DefinitionDescription                   PATH   10473-7   Immune stain     Both       0 Chymotryp Ag Tiss Ql ImStn           Antigen; Antigens; Chymotrypsine; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified 2.56 1.0i                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
104730-7 Influenza virus A H3 RNA PrThr XXX Pt Ord Molgen   ACTIVE Influenza virus A H3 RNA [Presence] in Specimen by Molecular genetics method   ADD DefinitionDescription                   MICRO   104730-7   Molgen     Observation       0 FLUAV H3 RNA Spec Ql       N   Avian influenza; Bird flu; FLUA; FLUAV; FLUAV H3; FLUV; Fowl plague; Influ; Influenza A; Influenza A virus; Microbiology; Misc; Miscellaneous; Molecular genetics; Ordinal; Other; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; Spec; To be specified in another part of the message; Unspecified 2.78 2.78                       0
104731-5 Clostridioides difficile toxin genes PrThr Stool Pt Ord Molgen   ACTIVE Clostridioides difficile toxin genes [Presence] in Stool by Molecular genetics method   ADD DefinitionDescription                   MICRO   104731-5   Molgen     Observation       0 C diff Tox gens Stl Ql       N   Bowel movement; C diff; C diff Tox; C diff Tox gens; C difficile; Clostridium difficile; Faecal; Faeces; Fecal; Feces; Microbiology; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal 2.78 2.78                       0
104732-3 HIV 1 Ab band pattern Imp Ser Pt Nom     ACTIVE HIV 1 Ab band pattern [Interpretation] in Serum   ADD DefinitionDescription                   MICRO   104732-3         Observation       0 HIV1 Ab Patrn Ser-Imp       N   Ab Patrn; ABS; Aby; AIDS; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bands; bnd; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Microbiology; Nominal; Patrn; Point in time; Random; Serum; SR 2.78 2.78                       0
104733-1 Maximum number of administrations Num ^Patient Pt Qn     ACTIVE Maximum number of administrations   ADD DefinitionDescription     #             MEDS   104733-1         Observation       0 Max num of admin       N   Cnt; Count; Max num of admin; MEDS; No; Num; Number; Point in time; QNT; Quan; Quant; Quantitative; Random 2.78 2.78               {#}       0
104734-9 Streptococcus.beta-hemolytic PrThr XXX Pt Ord     ACTIVE Streptococcus.beta-hemolytic [Presence] in Specimen   ADD DefinitionDescription                   MICRO   104734-9         Observation       0 B-Hem Strep Spec Ql       N   B; B-Hem Strep; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Strep; Strept; To be specified in another part of the message; Unspecified 2.78 2.78                       0
104735-6 Influenza virus B RNA PrThr XXX Pt Ord Molgen   ACTIVE Influenza virus B RNA [Presence] in Specimen by Molecular genetics method   ADD DefinitionDescription                   MICRO   104735-6   Molgen     Observation       0 FLUBV RNA Spec Ql       N   FLUB; FLUBV; FLUV; Influ; Influenza B; Influenza B virus; Microbiology; Misc; Miscellaneous; Molecular genetics; Ordinal; Other; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; Spec; To be specified in another part of the message; Unspecified 2.78 2.78                       0
104736-4 Clinician guidance Type Medication Pt Nar     ACTIVE Clinician guidance Medication Narrative   ADD DefinitionDescription                   MEDS   104736-4         Observation       0 Clinician guidance Medication       N   Guid; Guide; Guided; Med; MEDS; Narrative; Point in time; Random; Report; Typ 2.78 2.78                       0
104,672 results found